Mon panier

c-Myc

c-Myc Informations sur la molécule

Nom anglaisMyc proto-oncogene proteinNombre de médicaments commercialisés0
Nombre de médicaments cliniques10Alias de la cibleClass E Basic Helix-Loop-Helix Protein 39,Transcription Factor P64,Proto-Oncogene C-Myc,Myc-Related Translation/Localization Regulatory Factor,Avian Myelocytomatosis Viral Oncogene Homolog,V-Myc Myelocytomatosis Viral Oncogene Homolog,Myc Proto-Oncogene Protein,BHLHE39,C-Myc,MRTL,MYCC,Proto-Oncogene Proteins c-myc,MYC,MYC Proto-Oncogene, BHLH Transcription Factor,V-Myc Avian Myelocytomatosis Viral Oncogene Homolog
Phase de R&D la plus avancéePhase 2 Clinical
Nom anglaisMyc proto-oncogene protein
Alias de la cibleClass E Basic Helix-Loop-Helix Protein 39,Transcription Factor P64,Proto-Oncogene C-Myc,Myc-Related Translation/Localization Regulatory Factor,Avian Myelocytomatosis Viral Oncogene Homolog,V-Myc Myelocytomatosis Viral Oncogene Homolog,Myc Proto-Oncogene Protein,BHLHE39,C-Myc,MRTL,MYCC,Proto-Oncogene Proteins c-myc,MYC,MYC Proto-Oncogene, BHLH Transcription Factor,V-Myc Avian Myelocytomatosis Viral Oncogene Homolog
Nombre de médicaments commercialisés0
Nombre de médicaments cliniques10
Phase de R&D la plus avancéePhase 2 Clinical

c-Myc Liste de produits

  • Attribut

    Antibody (1)

  • Bibliothèque de produits

    En ligne (1)

  • Espèces

    Mouse (1)

  • Étiquette

    - (1)

  • Marqueur

    Unconjugated (1)

Numéro de produitEspècesSystème d'expressionDescription du produitStructure protéiquePuretéCaractéristiquesPré-commande/Commande
MYC-MMYCc
Mouse
HEK293
Anti c-Myc Tag Monoclonal Antibody (9E10) Ajouter au panier
Quantité totale1
  • 1

c-MycContexte de la molécule

The c-Myc tag is a widely used epitope tag in molecular biology for protein expression and detection. Derived from the human c-Myc oncoprotein. This tag is typically fused to target proteins through genetic engineering, allowing researchers to identify, purify, or track the expressed proteins using specific monoclonal antibodies.

c-MycAlias de la molécule

c-Myc,MYC,MRTL,bHLHe39

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
XNW-34017XNW-34017; XNW34017Phase 2 ClinicalEvopoint Biosciences Co LtdNeoplasm Metastasis; Solid tumours
Details
Sepantronium BromideYM-155; YM155 monobromide; PC-002Phase 2 ClinicalAstellas Pharma IncBreast Neoplasms; Burkitt Lymphoma; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Lymphatic Diseases; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Melanoma; Neoplasms; Prostatic Neoplasms; Solid tumours
Details
OMO-103OMO-103; OMO103Phase 2 ClinicalPeptomyc SLCarcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Osteosarcoma; Pancreatic Neoplasms; Solid tumours
Details
WP-1066WP-1066Phase 2 ClinicalMoleculin Biotech IncBrain metastases; Brain Neoplasms; Diffuse Intrinsic Pontine Glioma; Glioblastoma; Glioma; Medulloblastoma; Melanoma
Details
PLX-51107PLX-51107Phase 1 ClinicalPlexxikon IncGraft vs Host Disease; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Myelodysplastic Syndromes; Myelodysplastic-Myeloproliferative Diseases; Myeloproliferative Disorders; Solid tumours
Details
SACT-1SACT-1Phase 1 ClinicalAptorum Group LlcNeuroblastoma
Details
MyrtleciclibVS 2370; VS2-370Phase 1 ClinicalVichem ChemieHIV Infections; Neoplasms
Details
WBC100WBC100; WBC-100Phase 1 ClinicalHangzhou Weben Pharmaceutical Co LtdHematologic Neoplasms; Leukemia, Myeloid, Acute; Neoplasms; Solid tumours
Details
LuxeptinibCG026806; CG-806; CG’806; CG-026806Phase 1 ClinicalCrystalgenomics IncHematologic Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Myelodysplastic Syndromes
Details
MisetionamideGP-2250Phase 1 ClinicalGeistlich PharmaPancreatic Neoplasms
Details
  • Informations sur la molécule
  • Liste de produits
  • Informations sur les médicaments cliniques